エルゼビアが医学論文ゴーストライター問題について調査を表明

画像 医学出版大手のElsevier は、製品販促のため製薬会社により不適切に代作されたホルモン療法の記事を出版したとする上院議員の主張について調査すると発表した。
 医師への製薬会社の影響を調査している上院財務委員会のメンバーGrassley上院議員が、2003年5月号の American Journal of Obstetrics and Gynecology の記事“Editors' Choice”について問題提起した。オーストラリアの研究者 Dr. John Eden 署名記事で製薬会社ワイスの薬品に好意的に書かれたもので、ワイスが医学ゴーストライターに書かせたもので、医師は名前を連ねただけだと主張している。
(書きかけ)
-----------------
医学論文ゴーストライターへ製薬会社から報酬/米国医療事情
http://kurie.at.webry.info/200812/article_24.html
バイオックス研究のゴーストライター
http://kurie.at.webry.info/200804/article_30.html
------------------------------------------------------
Medical Publisher to Review Claim About Article’s Writer
http://www.nytimes.com/2008/12/20/business/20ghost.html

By DUFF WILSON
Published: December 19, 2008

Elsevier, a medical publisher, said Friday that it would investigate a senator’s recent allegation that one of its journals published an article on hormone replacement therapy that was improperly ghostwritten by a drug company promoting the product.

Senator Charles E. Grassley, Republican of Iowa, had raised questions about the May 2003 “Editors’ Choice” article in Elsevier’s American Journal of Obstetrics and Gynecology. The article, signed by Dr. John Eden, an Australia academic, was among articles Mr. Grassley has cited that were favorable to drugs made by the pharmaceutical company Wyeth.

Mr. Grassley, a member of the Senate Finance Committee who is investigating drug company influence on doctors, contends that Wyeth commissioned the articles and had them ghostwritten by a medical writing firm. Only after the articles were conceived and under way did the firm line up doctors to put their names on them, Mr. Grassley contends.

“The charges made by Senator Grassley’s office with regard to the article published in 2003 by Dr. Eden are a significant concern to The Journal and Elsevier,” Glen P. Campbell, the senior vice president for Elsevier’s US Health Sciences Journals unit, said in a statement. “As with any charge of misconduct or inappropriate publishing acts, The Journal has launched its own investigation into the claims of ghostwriting and undisclosed financial support.”

The journal article, published more than a year after a landmark federal study linked Wyeth’s Prempro hormone product to breast cancer in women, said there was “no definitive evidence” the hormones caused breast cancer.

Mr. Eden’s article did not mention any involvement by Wyeth or DesignWrite, the medical writing company hired by Wyeth. He acknowledged the contributions of two people for “editorial assistance” but did not disclose they worked for DesignWrite. The standard industry guidelines for medical journals require the authors to identify all significant contributors.

In an e-mail message to The New York Times last week, Mr. Eden said he stood by the article’s contents but declined to elaborate. “I cannot comment as these matters are before the Senate,” he said in the message. “I am also aware of ongoing lawsuits around these matters.” Mr. Eden is an associate professor at the University of New South Wales.

In a statement Friday, Wyeth said the academic authors were not paid by Wyeth and had “substantive editorial control” of the articles. Mr. Grassley said in a statement that he appreciated the publishing company’s response and would continue his own investigation

ブログ気持玉

クリックして気持ちを伝えよう!

ログインしてクリックすれば、自分のブログへのリンクが付きます。

→ログインへ

なるほど(納得、参考になった、ヘー)
驚いた
面白い
ナイス
ガッツ(がんばれ!)
かわいい

気持玉数 : 0

この記事へのコメント

この記事へのトラックバック